-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Propanc Biopharma, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q2 2013 to Q2 2025.
- Propanc Biopharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Jun 2025 was $25.5M, a 181% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)